Belatacept in Kidney Transplantation: What Are the True Benefits? A Systematic Review
The current gold standard to prevent allograft rejection for maintenance immunosuppression in kidney transplantation currently consists in glucocorticoids, an antiproliferative agent and a calcineurin inhibitor (CNI), with better outcome for tacrolimus than cyclosporin. Although, CNI drastically imp...
| Main Authors: | , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Frontiers Media S.A.
2022-07-01
|
| 叢編: | Frontiers in Medicine |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fmed.2022.942665/full |